The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

Getting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...

The shingles vaccine is recommended for healthy adults age 50 or older, and also for anyone age 19 years or older who has a weakened immune system (for example, if you have recently been treated for ...

Shingles are more common than people think but there is help in the form of a vaccination. SHINGRIX is an FDA-approved vaccine for the prevention of shingles in adults 50 years ...

Prominent outside scientists who help the NIH evaluate its internal research programs are being abruptly removed ...

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

The recombinant zoster vaccine is effective in preventing herpes zoster in adults aged 50 years or older with rheumatoid ...

GSK partners with UK research groups to study if Shingrix shingles vaccine reduces dementia risk, analyzing NHS data from ...

Then, when the newer, improved Shingrix vaccine became available, I was given the two-shot series in 2019. Feeling quite confident that I was well-protected, I was shocked when I was diagnosed ...

To test it prospectively, GSK will work with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) ...

GSK is collaborating with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to investigate whether GSK’s shingles vaccine, Shingrix (zoster vaccine recombinant ...